Zobrazeno 1 - 10
of 43
pro vyhledávání: '"O, Brekke"'
Autor:
J. J. Railhac, O. Brekke
Publikováno v:
European Radiology. 7:S135-S139
Objectives. This trial was designed to compare the incidence of delayed postprocedural pain after administration of iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) 300 mg I/ml versus ioxaglate (Hexabrix®, Guerbet, Aulnay-sous-Bois, France)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::845fe6f365fae28635681d069ef84730
https://doi.org/10.1007/pl00006880
https://doi.org/10.1007/pl00006880
Publikováno v:
Clinical Radiology. 51:210-213
To evaluate the safety and efficacy of iodixanol (Visipaque) in phlebography in order to obtain experience from the use of this contrast medium in this i.v. indication.Phlebography was performed in 150 patients, as a comparative prospective, double-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5814c64dbd41d0233e95359392aa87c6
https://doi.org/10.1016/s0009-9260(96)80325-4
https://doi.org/10.1016/s0009-9260(96)80325-4
Autor:
J. Fairhurst, R. Svihus, O. Brekke, K. Tveit, J. Grellet, G. Jenssen, A.-N. Dardenne, K. Skinningsrud, L. Lemaitre
Publikováno v:
Clinical Radiology. 50:44-48
The purpose of the present phase IV multicentre trial was to evaluate general patient tolerance to Omnipaque ® 350 mgI/ml (iohexol) supplied in polypropylene containers compared to that of the same product supplied in routinely used glass vials, wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc09a77cfa40dd75bfb9ebcb450ff5b5
https://doi.org/10.1016/s0009-9260(05)82964-2
https://doi.org/10.1016/s0009-9260(05)82964-2
Publikováno v:
Acta Radiologica. 36:64-68
Nineteen children received 99mTc-DTPA for renography. The next day they received a simultaneous injection of the non-ionic contrast medium iopentol for urography and another injection of 99mTc-DTPA. The glomerular filtration rate (GFR) was estimated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b9b1070912c951c227e81eba9750123
https://doi.org/10.3109/02841859509173349
https://doi.org/10.3109/02841859509173349
Publikováno v:
Pediatric Radiology. 24:107-110
The safety and diagnostic efficacy of the new non-ionic, monomeric contrast medium iopentol (Imagopaque) were evaluated and compared with those of the ionic medium metrizoate (Isopaque), in urography in children in a randomized, double-blind, paralle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3094fcb699fd5b5f3edac53757d63f70
https://doi.org/10.1007/bf02020165
https://doi.org/10.1007/bf02020165
Autor:
O. Brekke, P. Lanning
Publikováno v:
European Radiology. 7:S120-S122
A double-blind, parallel-group trial was performed in 96 children in order to evaluate and compare the safety and efficacy of iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) with those of routinely used contrast media. Ten children below 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe7c84dc5221102336d741a03d4a9589
https://doi.org/10.1007/pl00006876
https://doi.org/10.1007/pl00006876
Publikováno v:
European journal of radiology. 38(3)
A cubital intravenous iodine contrast agent enhancement is used to visualize coronary arteries using EBT. The quality of the coronary artery visualization however is limited by the nearly simultaneous approximation of CT values in coronary arteries a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8343747d1e3d9217526a2482e20076
https://pubmed.ncbi.nlm.nih.gov/11399369
https://pubmed.ncbi.nlm.nih.gov/11399369
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 50(3)
A crossover study was performed to compare the hemodynamic effects of the iso-osmolar contrast agent iodixanol (Visipaque) 320 mg I/ml to those of the low-osmolar iohexol (Omnipaque) 350 mg I/ml. The main hypothesis was that iodixanol and iohexol wou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9e20e8da64d34b6be6afcc630e4f4d26
https://pubmed.ncbi.nlm.nih.gov/10878628
https://pubmed.ncbi.nlm.nih.gov/10878628
Autor:
P, Lanning, O, Brekke
Publikováno v:
European radiology. 7
A double-blind, parallel-group trial was performed in 96 children in order to evaluate and compare the safety and efficacy of iopentol (Imagopaque, Nycomed imaging AS, Oslo, Norway) with those of routinely used contrast media. Ten children below 1 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::86ce2b053fbda0272d8c117e65d8578e
https://pubmed.ncbi.nlm.nih.gov/9204352
https://pubmed.ncbi.nlm.nih.gov/9204352
Publikováno v:
Acta radiologica (Stockholm, Sweden : 1987). 36(1)
Nineteen children received 99mTc-DTPA for renography. The next day they received a simultaneous injection of the non-ionic contrast medium iopentol for urography and another injection of 99mTc-DTPA. The glomerular filtration rate (GFR) was estimated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f7d6444a09dbe8062e81520833260e2
https://pubmed.ncbi.nlm.nih.gov/7833171
https://pubmed.ncbi.nlm.nih.gov/7833171